These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18855573)

  • 81. Inhibition of janus kinase 2 by compound AG490 suppresses the proliferation of MDA-MB-231 cells via up-regulating SARI (suppressor of AP-1, regulated by IFN).
    Zhang YX; Yan L; Liu GY; Chen WJ; Gong WH; Yu JM
    Iran J Basic Med Sci; 2015 Jun; 18(6):599-603. PubMed ID: 26221484
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hepcidin antagonists for potential treatments of disorders with hepcidin excess.
    Poli M; Asperti M; Ruzzenenti P; Regoni M; Arosio P
    Front Pharmacol; 2014; 5():86. PubMed ID: 24808863
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.
    Sun CC; Vaja V; Babitt JL; Lin HY
    Am J Hematol; 2012 Apr; 87(4):392-400. PubMed ID: 22290531
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun.
    Li Y; Samuvel DJ; Sundararaj KP; Lopes-Virella MF; Huang Y
    J Cell Biochem; 2010 May; 110(1):248-59. PubMed ID: 20225236
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism.
    Samuvel DJ; Sundararaj KP; Li Y; Lopes-Virella MF; Huang Y
    J Biol Chem; 2010 Feb; 285(6):3916-3927. PubMed ID: 20007708
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Avicin D: a protein reactive plant isoprenoid dephosphorylates Stat 3 by regulating both kinase and phosphatase activities.
    Haridas V; Nishimura G; Xu ZX; Connolly F; Hanausek M; Walaszek Z; Zoltaszek R; Gutterman JU
    PLoS One; 2009; 4(5):e5578. PubMed ID: 19440292
    [TBL] [Abstract][Full Text] [Related]  

  • 87. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
    Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
    J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
    Swiatek-Machado K; Mieczkowski J; Ellert-Miklaszewska A; Swierk P; Fokt I; Szymanski S; Skora S; Szeja W; Grynkiewicz G; Lesyng B; Priebe W; Kaminska B
    Cancer Biol Ther; 2012 Jun; 13(8):657-70. PubMed ID: 22555804
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ; Du C; Sriram S
    J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
    [TBL] [Abstract][Full Text] [Related]  

  • 90. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J; Jourdan M; Tarte K; Jasmin C; Klein B
    Br J Haematol; 2000 Jun; 109(4):823-8. PubMed ID: 10929036
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
    Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490.
    Caceres-Cortes JR
    Anticancer Agents Med Chem; 2008 Oct; 8(7):717-22. PubMed ID: 18855573
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
    Abbaspour Babaei M; Kamalidehghan B; Saleem M; Huri HZ; Ahmadipour F
    Drug Des Devel Ther; 2016; 10():2443-59. PubMed ID: 27536065
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.